90 related articles for article (PubMed ID: 25912382)
1. vRNA structured population model for Hepatitis C Virus dynamics.
Woot de Trixhe X; Krzyzanski W; De Ridder F; Vermeulen A
J Theor Biol; 2015 Aug; 378():1-11. PubMed ID: 25912382
[TBL] [Abstract][Full Text] [Related]
2. Understanding hepatitis C viral dynamics with direct-acting antiviral agents due to the interplay between intracellular replication and cellular infection dynamics.
Guedj J; Neumann AU
J Theor Biol; 2010 Dec; 267(3):330-40. PubMed ID: 20831874
[TBL] [Abstract][Full Text] [Related]
3. The importance of rapid viral suppression in the era of directly acting antiviral therapy for hepatitis C virus.
Jenkins ET; Jensen DM
Infect Dis Clin North Am; 2012 Dec; 26(4):879-91. PubMed ID: 23083821
[TBL] [Abstract][Full Text] [Related]
4. 3D Spatially Resolved Models of the Intracellular Dynamics of the Hepatitis C Genome Replication Cycle.
Knodel MM; Reiter S; Targett-Adams P; Grillo A; Herrmann E; Wittum G
Viruses; 2017 Sep; 9(10):. PubMed ID: 28973992
[TBL] [Abstract][Full Text] [Related]
5. [Molecular virology of hepatitis C].
Moradpour D; Brass V; Gosert R; Wölk B; Blum HE
Praxis (Bern 1994); 2002 Dec; 91(51-52):2247-53. PubMed ID: 12564041
[TBL] [Abstract][Full Text] [Related]
6. Effect of interferon alfa on the dynamics of hepatitis C virus turnover in vivo.
Zeuzem S; Schmidt JM; Lee JH; Rüster B; Roth WK
Hepatology; 1996 Feb; 23(2):366-71. PubMed ID: 8591865
[TBL] [Abstract][Full Text] [Related]
7. Disentangling the lifespans of hepatitis C virus-infected cells and intracellular vRNA replication-complexes during direct-acting anti-viral therapy.
Cardozo EF; Ji D; Lau G; Schinazi RF; Chen GF; Ribeiro RM; Perelson AS
J Viral Hepat; 2020 Mar; 27(3):261-269. PubMed ID: 31670859
[TBL] [Abstract][Full Text] [Related]
8. Twenty-four hour kinetics of hepatitis C virus and antiviral effect of alpha-interferon.
Boulestin A; Kamar N; Sandres-Sauné K; Legrand-Abravanel F; Alric L; Vinel JP; Rostaing L; Izopet J
J Med Virol; 2006 Mar; 78(3):365-71. PubMed ID: 16419107
[TBL] [Abstract][Full Text] [Related]
9. Mathematical modeling of HCV infection and treatment.
Dahari H; Shudo E; Ribeiro RM; Perelson AS
Methods Mol Biol; 2009; 510():439-53. PubMed ID: 19009281
[TBL] [Abstract][Full Text] [Related]
10. Analysis of hepatitis C virus decline during treatment with the protease inhibitor danoprevir using a multiscale model.
Rong L; Guedj J; Dahari H; Coffield DJ; Levi M; Smith P; Perelson AS
PLoS Comput Biol; 2013; 9(3):e1002959. PubMed ID: 23516348
[TBL] [Abstract][Full Text] [Related]
11. Dynamics of hepatitis C virus replication in human liver.
Chang M; Williams O; Mittler J; Quintanilla A; Carithers RL; Perkins J; Corey L; Gretch DR
Am J Pathol; 2003 Aug; 163(2):433-44. PubMed ID: 12875965
[TBL] [Abstract][Full Text] [Related]
12. Triphasic decline of hepatitis C virus RNA during antiviral therapy.
Dahari H; Ribeiro RM; Perelson AS
Hepatology; 2007 Jul; 46(1):16-21. PubMed ID: 17596864
[TBL] [Abstract][Full Text] [Related]
13. HCV RNA viral load assessments in the era of direct-acting antivirals.
Cobb B; Pockros PJ; Vilchez RA; Vierling JM
Am J Gastroenterol; 2013 Apr; 108(4):471-5. PubMed ID: 23552304
[TBL] [Abstract][Full Text] [Related]
14. The hepatitis C virus life cycle as a target for new antiviral therapies.
Pawlotsky JM; Chevaliez S; McHutchison JG
Gastroenterology; 2007 May; 132(5):1979-98. PubMed ID: 17484890
[TBL] [Abstract][Full Text] [Related]
15. Primary cultures of human hepatocytes isolated from hepatitis C virus-infected cirrhotic livers as a model to study hepatitis C infection.
Raymond VA; Selliah S; Ethier C; Houle R; Jouan L; Maniere T; Lamarre D; Willems B; Bilodeau M
Liver Int; 2009 Jul; 29(6):942-9. PubMed ID: 19302183
[TBL] [Abstract][Full Text] [Related]
16. Low hepatitis C viral load predicts better long-term outcomes in patients undergoing resection of hepatocellular carcinoma irrespective of serologic eradication of hepatitis C virus.
Shindoh J; Hasegawa K; Matsuyama Y; Inoue Y; Ishizawa T; Aoki T; Sakamoto Y; Sugawara Y; Makuuchi M; Kokudo N
J Clin Oncol; 2013 Feb; 31(6):766-73. PubMed ID: 23129744
[TBL] [Abstract][Full Text] [Related]
17. Release of virus from lymphoid tissue affects human immunodeficiency virus type 1 and hepatitis C virus kinetics in the blood.
Müller V; Marée AF; De Boer RJ
J Virol; 2001 Mar; 75(6):2597-603. PubMed ID: 11222682
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus and hepatitis C virus interaction in Huh-7 cells.
Eyre NS; Phillips RJ; Bowden S; Yip E; Dewar B; Locarnini SA; Beard MR
J Hepatol; 2009 Sep; 51(3):446-57. PubMed ID: 19596477
[TBL] [Abstract][Full Text] [Related]
19. Quantitation of hepatitis C virus RNA in peripheral blood mononuclear cells in HCV-monoinfection and HIV/HCV-coinfection.
Chary A; Winters MA; Eisen R; Knight TH; Asmuth DM; Holodniy M
J Med Virol; 2012 Mar; 84(3):431-7. PubMed ID: 22246828
[TBL] [Abstract][Full Text] [Related]
20. [Inhibition of hepatitis C virus replication by mycophenolic acid in hepatocytes].
Chen H; Ye L; Su JM; Li Y; Zeng JR; Huo WZ
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2013 Feb; 27(1):35-8. PubMed ID: 23855126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
